CLINICAL STUDY PLAN AND TRIAL DESIGN
Leverage Pentara's world-leading expertise in innovative study design and analysis to accelerate the success of effective treatments and efficiently identify ineffective ones.
Preparation
Our deep understanding of clinical trials in progressive diseases enables our research team to perform targeted literature reviews for superior study design.
Development
Pentara’s statisticians strategically determine optimal outcomes, sample size, modeling, adaptations, corrections, inference, and overall study strategy, informed by comprehensive data insights, including our proprietary integrated historical data.
Analysis
We offer a unique integrated statistical perspective throughout the clinical trial lifecycle, from EDC design to final reporting, ensuring data integrity and study power. Additionally, we provide efficient medical coding using MedDRA and WHO Drug dictionaries.
STATISTICAL SECOND OPINION
We also provide independent statistical second opinions, rapidly confirming prior analyses through replication and novel post-hoc explorations. This trusted independent validation empowers strategic decision-making for companies and investors.
